Keywords: hra, pharma, licensing, deal, preglem, ulipristal, paris

HRA Pharma in licensing deal with PregLem for ulipristal

Article | 10 December 2007

Print This

Paris, France-based HRA Pharma, which is developing medicines and products for women's health and endocrine disease, has entered into a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in